A comprehensive pan-cancer analysis reveals grb7 as a potential diagnostic and prognostic biomarker

HIGHLIGHTS

• What: The analysis focused on estimating the abundance of six types of immune cells - B cells, CD4+ T_cells, CD8+ T_cells, neutrophils, macrophages, and dendritic cells across various cancer types. The analysis showed that increased GRB7 expression was correlated with significantly poorer OS and RFS in OV (OS: HR=1.61, p=0.00037; RFS: HR=1.54, p=0.019), PAAD (OS: HR=2.02, p=0.00068; RFS: HR=3.98, p=0.016), TGCT (OS: HR=582885929.78, p=0.048; RFS: HR=2.31, p=0.026), and UCEC (OS: HR=2.53, p . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.